Client’s Testimonial:
“Thank you very much for your great services and guidance.”
On February 1st, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Lecturer in the Field of Drug Delivery (Approval Notice).
General Field: Drug Delivery
Position at the Time of Case Filing: Senior Lecturer
Country of Origin: Syria
Country of Residence at the Time of Filing: Malaysia
Approval Notice Date: February 1st, 2023
Processing Time: 5 months, 23 days
Case Summary:
When a senior Syrian lecturer with a Ph.D. in pharmaceuticals working in drug delivery came to our firm for his National Interest Waiver application, our team made sure that he was academically and professionally equipped to deal with the requirements of the case. As an expert in the field of drug delivery, his proposed endeavor was to work on developing new oral insulin delivery materials and drug delivery carriers with a one-step reproducible process in order to develop DNA and RNA vaccines to treat cancer and other diseases. Other information pieces that came in handy to prove his worth for the nation and the scientific community are as follows:
- His endeavor is of great importance because it improves treatment for a range of conditions. He has developed nanocarriers for insulin to treat diabetes. His research is conducive to improving treatment for diabetes, and thus, it addresses a major public health concern. Overall, his work represents an important advancement in pharmaceutical development, because nanocarriers for drug delivery have a number of benefits.
- His proposed endeavor also has broad implications for the United States as he has devoted great effort to improving treatment for diabetes and cancer by developing nanoparticle-based drug delivery systems for these conditions.
- This is why of his 4 recommendations, 2 experts wrote:
“Diabetes, cancer, and viral infections pose a problem for the United States, and [the client’s] research addresses each of these areas through the development of novel drug delivery systems. As such, it is important to develop new drugs and more effective drug delivery technologies to help patients manage these diseases, while also lowering the costs associated with diabetes and cancers. Given his expertise in the design and development of such methods, especially orally administrated and targeted drug delivery technologies, [the client’s] ongoing research is indeed important to the United States.”
“One area of major significance in [the client’s] research is his work on the creation of orally administrable insulin. Normally, when insulin is administered orally, it is decomposed once it encounters stomach acid, rendering it ineffective for managing diabetes. Through his work, [the client] has created a specially suited drug delivery system for oral insulin to preserve the insulin through the stomach acid to allow for absorption in the intestine. Thus, his work is of tremendous national value. Considering the value of [the client] in the field of drug delivery research to these and similar national issues, his ongoing work is of clear and irrefutable significance to the United States.”
Not only this but in the 8 years of his consistent work, he has been invited to conduct peer reviews at least 9 times to date and his research has resulted in 14 peer-reviewed journal articles (3 of them first-authored and 6 of them corresponding-authored) and 3 first-authored book chapters. These research publications have also gone on to influence his peers. That is, they have been cited a total of 105 times according to Google Scholar.
Given these favorable facts, our client’s case got an approval in less than 6 months, and that too without an RFE. We are grateful to him for choosing our firm and we wish him the best for the future.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation: https://www.wegreened.com/Free-Evaluation
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.